Portfolio of Renaissance Technologies

Renaissance Technologies was founded by Jim Simons († 2024) and makes investment decisions with mathematical models; the portfolio holds a very large number of stocks.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 11, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2021. Go to the latest filing (Q3 2026)

80.4B USDQ4 2021
Total value of stock positions
80.4B USD
Positions
3,860
Share of the ten largest
11.6%

The ten largest positions Q4 2021

  1. Novo Nordisk (ADR) 2.7%▼ −11.7%
  2. Atlassian 1.4%▼ −8.7%
  3. Verisign 1.3%▼ −10.2%
  4. Kroger 1.0%▼ −5.0%
  5. Microsoft 1.0%▼ −21.2%
  6. Tesla, Inc. 1.0%▼ −8.7%
  7. Zoom Video Communications In 0.9%▲ +24.5%
  8. Gilead Sciences 0.8%▲ +65.1%
  9. United Therapeutics Corp Del 0.8%▼ −3.7%
  10. Monster Beverage 0.8%▼ −6.0%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 130.1B USD).
Choose a quarter (54 filings)

All positions Q4 2021

Positions Q4 2021 per 13F filing, 50 of 1629
Symbol Weight Shares Reported value Change Held since
NVO Novo Nordisk (ADR) 2.7% 19,116,871 2.1B USD −11.7% reduced Q2 2013 or earlier 35 quarters
TEAM Atlassian 1.4% 2,903,320 1.1B USD −8.7% reduced Q2 2016 23 quarters
VRSN Verisign 1.3% 4,149,890 1.1B USD −10.2% reduced Q2 2013 or earlier 35 quarters
KR Kroger 1.0% 17,650,310 798.9M USD −5.0% reduced Q2 2019 11 quarters
MSFT Microsoft 1.0% 2,336,398 785.8M USD −21.2% reduced Q3 2020 6 quarters
TSLA Tesla, Inc. 1.0% 743,475 785.7M USD −8.7% reduced Q4 2018 13 quarters
United Therapeutics Corp Del 0.8% 2,917,191 630.3M USD −3.7% reduced Q2 2013 or earlier 35 quarters
MNST Monster Beverage 0.8% 6,496,560 623.9M USD −6.0% reduced Q1 2014 32 quarters
HSY Hershey Company (The) 0.8% 3,184,386 616.1M USD −2.5% reduced Q2 2013 or earlier 35 quarters
Molina Healthcare Inc 0.8% 1,911,315 608.0M USD −6.7% reduced Q2 2013 or earlier 35 quarters
Franco Nev Corp 0.7% 4,122,903 570.2M USD −8.8% reduced Q1 2014 32 quarters
DPZ Domino's 0.7% 955,878 539.4M USD −28.0% reduced Q2 2013 or earlier 35 quarters
Abiomed Inc 0.6% 1,451,300 521.3M USD −7.2% reduced Q1 2015 28 quarters
MRNA Moderna 0.6% 1,833,722 465.7M USD −8.3% reduced Q4 2020 5 quarters
Icon PLC 0.5% 1,417,758 439.1M USD −8.8% reduced Q2 2013 or earlier 35 quarters
Vodafone Group PLC New 0.5% 26,050,832 388.9M USD −8.8% reduced Q3 2015 26 quarters
TGT Target Corporation 0.5% 1,656,720 383.4M USD −46.3% reduced Q1 2019 12 quarters
FTNT Fortinet 0.5% 1,012,789 364.0M USD −4.4% reduced Q3 2015 26 quarters
VRTX Vertex Pharmaceuticals 0.4% 1,626,868 357.3M USD −14.0% reduced Q1 2017 20 quarters
National Grid PLC 0.4% 4,925,268 356.2M USD −4.6% reduced Q2 2017 19 quarters
Herbalife Nutrition Ltd 0.4% 8,394,564 343.6M USD −4.0% reduced Q3 2015 26 quarters
AZN AstraZeneca 0.4% 5,818,828 338.9M USD −15.5% reduced Q1 2019 12 quarters
FFIV F5, Inc. 0.4% 1,361,062 333.1M USD −11.5% reduced Q3 2014 30 quarters
BMY Bristol Myers Squibb 0.4% 5,040,786 314.3M USD −29.2% reduced Q2 2016 23 quarters
Exelixis Inc 0.4% 17,100,778 312.6M USD −2.5% reduced Q3 2016 22 quarters
Cboe Global Mkts Inc 0.4% 2,310,824 301.3M USD −5.9% reduced Q2 2013 or earlier 35 quarters
ABBV AbbVie 0.3% 2,053,577 278.1M USD −0.8% reduced Q1 2018 16 quarters
Horizon Therapeutics Pub L 0.3% 2,277,066 245.4M USD −30.0% reduced Q2 2019 11 quarters
PG Procter & Gamble 0.3% 1,420,118 232.3M USD −16.4% reduced Q1 2020 8 quarters
CLX Clorox 0.3% 1,287,130 224.4M USD −0.5% reduced Q2 2013 or earlier 35 quarters
Jazz Pharmaceuticals PLC 0.3% 1,700,509 216.6M USD −14.9% reduced Q2 2015 27 quarters
Dropbox Inc 0.3% 8,446,333 207.3M USD −12.0% reduced Q1 2019 12 quarters
GE GE Aerospace 0.3% 2,174,079 205.4M USD −10.2% reduced Q1 2019 12 quarters
PEP PepsiCo 0.2% 1,141,062 198.2M USD −33.5% reduced Q1 2021 4 quarters
Cable One Inc 0.2% 110,800 195.4M USD −13.6% reduced Q4 2015 25 quarters
CL Colgate-Palmolive 0.2% 2,261,386 193.0M USD −33.6% reduced Q2 2013 or earlier 35 quarters
National Beverage Corp 0.2% 4,242,944 192.3M USD −1.7% reduced Q2 2013 or earlier 35 quarters
Corvel Corp 0.2% 902,210 187.7M USD −4.9% reduced Q2 2013 or earlier 35 quarters
PSA Public Storage 0.2% 490,608 183.8M USD −1.0% reduced Q2 2016 23 quarters
AZO AutoZone 0.2% 87,400 183.2M USD −8.0% reduced Q3 2021 2 quarters
Sprouts Fmrs Mkt Inc 0.2% 5,770,332 171.3M USD −2.1% reduced Q2 2016 23 quarters
Mobile Telesystems Pub Jt St 0.2% 21,169,574 168.3M USD −0.2% reduced Q3 2014 30 quarters
Medifast Inc 0.2% 797,610 167.0M USD −5.1% reduced Q2 2013 or earlier 35 quarters
Fortis Inc 0.2% 3,453,861 166.7M USD −7.0% reduced Q4 2016 21 quarters
Firstservice Corp New 0.2% 833,788 163.8M USD −0.4% reduced Q2 2019 11 quarters
Nova Ltd 0.2% 1,101,486 161.4M USD −5.4% reduced Q2 2013 or earlier 35 quarters
KDP Keurig Dr Pepper 0.2% 4,333,061 159.7M USD −4.0% reduced Q2 2019 11 quarters
Cogent Communications HLDGS 0.2% 2,178,356 159.4M USD −2.7% reduced Q2 2013 or earlier 35 quarters
Corcept Therapeutics Inc 0.2% 8,023,616 158.9M USD −2.7% reduced Q1 2015 28 quarters
NKE Nike, Inc. 0.2% 906,584 151.1M USD −74.7% reduced Q1 2021 4 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 largest of 1,629 positions.

Breakdown by sector

  • Technology 8.3%
  • Health Care 6.6%
  • Consumer Staples 6.3%
  • Consumer Discretionary 4.8%
  • Financials 4.2%
  • Industrials 3.5%
  • Communication Services 3.2%
  • Energy 1.7%
  • Utilities 1.4%
  • Materials 1.1%
  • Real Estate 0.9%
  • not in our coverage 58.0%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close